News and Announcements
MedAdvisor Signs Pfizer for Patient Engagement Program
- Published December 08, 2016 10:27AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
8th December 2016 – ASX Announcement
- MedAdvisor signs Pfizer, the world’s largest research-based pharmaceutical company to deliver a patient engagement program (PEP) on its platform
- Pfizer will use the MedAdvisor platform to deliver information and advice to patients to enhance and promote the safe and effective use of its medication
- Pfizer develops, manufactures and distributes hundreds of prescription medicines, vaccines and over-the-counter products
- Agreement with Pfizer and renewed programs provide strong validation of the value the PEPs are delivering pharmaceutical manufacturers and the Company’s ability to grow this revenue stream
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has entered into an agreement with Pfizer Australia Pty Limited (Pfizer) to provide a Patient Engagement Program (PEP) for one of its leading medications.
MedAdvisor will work with Pfizer to deliver important information and guidance to patients prescribed with this Pfizer medication. Preparation for the program has already commenced and it will run for an initial period of 18 months.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
